MCB raises USD350m in Syndicated Loan from Asia

2025-02-20 IDOPRESS

PORT LOUIS,Republic of Mauritius,Feb. 19,2025 -- The Mauritius Commercial Bank Ltd successfully closed its first Dual Tranche Asia-focused Syndicated Term Loan of USD350m. Initially launched at USD300m,the facility was very well received and was oversubscribed two times from a total of 20 banks,allowing MCB to upsize the facility to USD350m subsequently. The proceeds of the Facility will be used by MCB for general corporate purposes.

This landmark transaction,which includes MCB's debut 5-year syndicated loan and launched exclusively to Asian Lenders,is a testament to the confidence placed by international lenders in MCB's creditworthiness and strategy. The syndication was launched with a physical roadshow in Hong Kong,Beijing,Shanghai,Taipei,and Seoul,generating significant interest from lenders across all these jurisdictions,including India,with a number of these banks being first-time lenders to MCB. With the diversification of its lenders' pool to Asian lenders,MCB has also been successful in substantially tightening its cost of borrowing.

Anbar Jowaheer,Head of Financial Institutions and Syndication,MCB: "This new facility continues the success of MCB's funding program aimed at diversifying its funding sources through new markets. The significant participation in the 5-year tranche underscores the trust of international investors in MCB's strategy."

Thierry Hebraud,CEO,MCB Ltd: "Expanding our investor base to Asian lenders marks a significant milestone for MCB,particularly in view of the Asia – Africa corridor of the Mauritius IFC. This facility is a testimony to the global investor confidence placed in MCB's strategy,its investment grade ratings,and its growth potential."

Industrial and Commercial Bank of China Limited,London Branch,Mizuho Bank,Ltd. and Standard Chartered acted as Bookrunners,Initial Mandated Lead Arrangers,and Roadshow Coordinators for the Facility.

Visit http://mcbgroup.comto learn more about MCB.

Contact:Nicolas Teisserenc,nicolas@poinciana.co

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

2The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

6MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

©copyright 2009-2020 Singapore Info Map